Basics |
Merck & Co., Inc.
Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products.
|
IPO Date: |
January 2, 1990 |
Sector: |
Healthcare |
Industry: |
Pharma |
Market Cap: |
$194.83B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.51 | 0.89%
|
Avg Daily Range (30 D): |
$1.21 | 1.54%
|
Avg Daily Range (90 D): |
$1.28 | 1.51%
|
Institutional Daily Volume |
Avg Daily Volume: |
10.59M |
Avg Daily Volume (30 D): |
11.85M |
Avg Daily Volume (90 D): |
12.8M |
Trade Size |
Avg Trade Size (Sh.): |
178 |
Avg Trade Size (Sh.) (30 D): |
85 |
Avg Trade Size (Sh.) (90 D): |
85 |
Institutional Trades |
Total Inst.Trades: |
166,162 |
Avg Inst. Trade: |
$5.43M |
Avg Inst. Trade (30 D): |
$9.89M |
Avg Inst. Trade (90 D): |
$12.4M |
Avg Inst. Trade Volume: |
.09M |
Avg Inst. Trades (Per Day): |
30 |
Market Closing Trades |
Avg Closing Trade: |
$86.11M |
Avg Closing Trade (30 D): |
$171.74M |
Avg Closing Trade (90 D): |
$241.49M |
Avg Closing Volume: |
1.16M |
|
|
|
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
$2.01
|
$1.48
|
$6.76
|
Diluted EPS
|
$2.01
|
$1.48
|
$6.74
|
Revenue
|
$ 15.53B
|
$ 15.62B
|
$ 64.17B
|
Gross Profit
|
$ 12.11B
|
$ 11.8B
|
$ 48.98B
|
Net Income / Loss
|
$ 5.09B
|
$ 3.74B
|
$ 17.13B
|
Operating Income / Loss
|
$ 5.9B
|
$ 4.17B
|
$ 19.94B
|
Cost of Revenue
|
$ 3.42B
|
$ 3.83B
|
$ 15.19B
|
Net Cash Flow
|
$ -4586M
|
$ -1370M
|
$ 6.41B
|
PE Ratio
|
37.66
|
|
|
|